This condition — the plain-language one-pager.

What is GERD?Diagnosis

Gastroesophageal Reflux Disease (GERD) is when stomach acid (and sometimes bile) regularly flows backward into the esophagus. About 1 in 5 US adults has GERD. Mild symptoms (heartburn, regurgitation) are very treatable. Untreated chronic GERD causes esophagitis, strictures, Barrett's esophagus (precancerous), and rarely esophageal adenocarcinoma. The good news: stepwise lifestyle + medication therapy controls symptoms in nearly everyone — with surgery (Nissen, LINX) reserved for the small fraction who don't respond.

• Classic symptoms — Heartburn (retrosternal burning after meals or lying down), regurgitation, water brash, sour taste, chronic cough or asthma worsening, hoarseness, throat clearing, dental erosion, sleep disruption.
• Alarm symptoms — Dysphagia, odynophagia, weight loss, GI bleeding, anemia, persistent vomiting, age >50 with new symptoms — all trigger upper endoscopy (EGD).
• Diagnosis — Often clinical + response to PPI trial. EGD if alarm symptoms, refractory disease, or screening for Barrett's. Ambulatory pH monitoring or impedance for refractory cases.
• Stepwise treatment — Step 1: lifestyle (weight loss, head-of-bed elevation, no late meals, avoid trigger foods, smoking cessation, alcohol moderation); Step 2: H2 blockers (famotidine) for mild/intermittent; Step 3: PPI daily (omeprazole, pantoprazole, esomeprazole) — usually 4-8 weeks initial, then taper to lowest effective dose; Step 4: surgery (Nissen fundoplication, LINX magnetic ring) or endoscopic (TIF) for refractory or PPI-intolerant.

Barrett's surveillance — the precancer worth knowing aboutKnow your plan

About 10-15% of long-standing GERD patients develop Barrett's esophagus — a metaplastic change in the lower esophagus that raises esophageal adenocarcinoma risk. Caught early, Barrett's is treatable; caught late, esophageal cancer is one of the deadliest. Surveillance + endoscopic ablation has dramatically changed outcomes.

• Screen for Barrett's — Once in life for adults with chronic GERD >5 years + risk factors (age >50, male, white, smoker, obesity, family history). Now possible with non-endoscopic capsule (Cytosponge, EsoGuard) in some settings.
• If Barrett's diagnosed — surveillance EGD per dysplasia status: no dysplasia q3-5 years; low-grade dysplasia confirmed → endoscopic eradication (RFA + EMR); high-grade dysplasia → endoscopic eradication promptly.
• Aggressive acid control — high-dose PPI; lifestyle; weight loss; smoking + alcohol cessation.
• Tell every clinician about Barrett's — affects screening intervals, anti-acid intensity, surgical decisions.

Your daily Force FieldLive It

• Lifestyle is foundation — weight loss (most important), head-of-bed elevation 6-8 inches, no eating within 3 hours of lying down, identify and avoid trigger foods (chocolate, mint, fatty/fried, citrus, tomato, onion, alcohol, caffeine).
• No tobacco; alcohol moderation.
• Take PPI 30 min before breakfast on empty stomach for best efficacy.
• Step-down PPI to lowest effective dose after symptoms controlled — long-term high-dose PPI carries some risks (bone, B12, kidney, C. diff) though benefits outweigh in many.
• Recognize alarm symptoms — dysphagia, weight loss, GI bleeding → EGD.
• Barrett's surveillance on schedule if diagnosed.
• Address overlap conditions — sleep apnea worsens GERD; treat OSA; functional dyspepsia or eosinophilic esophagitis can mimic.
• Pregnancy GERD — H2 blockers + PPIs both used; lifestyle measures first.
• Refractory GERD — confirm diagnosis with pH study; consider EoE, hypersensitive esophagus, alkaline reflux; surgical/endoscopic options.

Red flags — call nowAction

• Call your clinic the same day for: new chest discomfort with exertion that goes away with rest (stable abdominal pain worth evaluating); a missed dose of antiplatelet or maintenance therapy; medication side effects (muscle aches, bleeding, GI symptoms).
• Bring up at next visit: any change in exercise tolerance, lipid follow-up timing, BP log review, smoking-cessation support, depression screening, sleep concerns.